330 related articles for article (PubMed ID: 33140140)
1. Seaweed-associated heterotrophic bacteria: new paradigm of prospective anti-infective and anticancer agents.
Kizhakkekalam VK; Chakraborty K
Arch Microbiol; 2021 Apr; 203(3):1241-1250. PubMed ID: 33140140
[TBL] [Abstract][Full Text] [Related]
2. Novel amylomacins from seaweed-associated Bacillus amyloliquefaciens as prospective antimicrobial leads attenuating resistant bacteria.
Chakraborty K; Kizhakkekalam VK; Joy M; Chakraborty RD
World J Microbiol Biotechnol; 2021 Oct; 37(12):200. PubMed ID: 34664128
[TBL] [Abstract][Full Text] [Related]
3. Marine macroalgae-associated heterotrophic Firmicutes and Gamma-proteobacteria: prospective anti-infective agents against multidrug resistant pathogens.
Kizhakkekalam VK; Chakraborty K
Arch Microbiol; 2020 May; 202(4):905-920. PubMed ID: 31897537
[TBL] [Abstract][Full Text] [Related]
4. Macrocyclic polyketides with siderophore mode of action from marine heterotrophic Shewanella algae: Prospective anti-infective leads attenuate drug-resistant pathogens.
Chakraborty K; Kizhakkekalam VK; Joy M
J Appl Microbiol; 2021 May; 130(5):1552-1570. PubMed ID: 33006801
[TBL] [Abstract][Full Text] [Related]
5. Oxygenated elansolid-type of polyketide spanned macrolides from a marine heterotrophic Bacillus as prospective antimicrobial agents against multidrug-resistant pathogens.
Kizhakkekalam VK; Chakraborty K; Joy M
Int J Antimicrob Agents; 2020 Mar; 55(3):105892. PubMed ID: 31926284
[TBL] [Abstract][Full Text] [Related]
6. Chemical mining of heterotrophic Shewanella algae reveals anti-infective potential of macrocyclic polyketides against multidrug-resistant pathogens.
Chakraborty K; Kizhakkekalam VK; Joy M
Bioorg Chem; 2021 Mar; 108():104533. PubMed ID: 33342567
[TBL] [Abstract][Full Text] [Related]
7. Moving away from traditional antibiotic treatment: can macrocyclic lactones from marine macroalga-associated heterotroph be the alternatives?
Chakraborty K; Kizhakkekalam VK; Joy M; Chakraborty RD
Appl Microbiol Biotechnol; 2020 Aug; 104(16):7117-7130. PubMed ID: 32621124
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of marine macroalgae-associated heterotrophic bacteria.
Kizhakkekalam VK; Chakraborty K
Arch Microbiol; 2019 May; 201(4):505-518. PubMed ID: 30406296
[TBL] [Abstract][Full Text] [Related]
9. Polyketide-derived macrobrevins from marine macroalga-associated Bacillus amyloliquefaciens as promising antibacterial agents against pathogens causing nosocomial infections.
Chakraborty K; Kizhakkekalam VK; Joy M
Phytochemistry; 2022 Jan; 193():112983. PubMed ID: 34695706
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic-active heterotrophic Firmicutes sheltered in seaweeds: can they add new dimensions to future antimicrobial agents?
Chakraborty K; Varghese C; Asharaf S; Chakraborty RD
Arch Microbiol; 2022 Feb; 204(3):183. PubMed ID: 35179656
[TBL] [Abstract][Full Text] [Related]
11. Marine macroalga-associated heterotrophic Bacillus velezensis: a novel antimicrobial agent with siderophore mode of action against drug-resistant nosocomial pathogens.
Chakraborty K; Francis A; Chakraborty RD; Asharaf S; Kizhakkekalam VK; Paulose SK
Arch Microbiol; 2021 Nov; 203(9):5561-5575. PubMed ID: 34436634
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial aryl-crowned polyketide from Bacillus subtilis associated with seaweed Anthophycus longifolius.
Chakraborty K; Thilakan B; Kizhakkekalam VK
J Appl Microbiol; 2018 Jan; 124(1):108-125. PubMed ID: 29108108
[TBL] [Abstract][Full Text] [Related]
13. Seaweed-associated heterotrophic bacteria: are they future novel sources of antimicrobial agents against drug-resistant pathogens?
Asharaf S; Chakraborty K; Chakraborty RD
Arch Microbiol; 2022 Mar; 204(4):232. PubMed ID: 35355132
[TBL] [Abstract][Full Text] [Related]
14. Seaweed-associated heterotrophic Bacillus altitudinis MTCC13046: a promising marine bacterium for use against human hepatocellular adenocarcinoma.
Asharaf S; Chakraborty K
Arch Microbiol; 2022 Dec; 205(1):10. PubMed ID: 36459289
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial and anticancer potential of marine endophytic actinomycetes Streptomyces coeruleorubidus GRG 4 (KY457708) compound against colistin resistant uropathogens and A549 lung cancer cells.
Rajivgandhi G; Muneeswaran T; Maruthupandy M; Ramakritinan CM; Saravanan K; Ravikumar V; Manoharan N
Microb Pathog; 2018 Dec; 125():325-335. PubMed ID: 30243551
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological potential of seaweed-associated heterotrophic Firmicutes.
Asharaf S; Chakraborty K
Lett Appl Microbiol; 2022 Oct; 75(4):1042-1054. PubMed ID: 35771159
[TBL] [Abstract][Full Text] [Related]
17. Bacillibactin class of siderophore antibiotics from a marine symbiotic Bacillus as promising antibacterial agents.
Chakraborty K; Kizhakkekalam VK; Joy M; Chakraborty RD
Appl Microbiol Biotechnol; 2022 Jan; 106(1):329-340. PubMed ID: 34913995
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial polyketide furanoterpenoids from seaweed-associated heterotrophic bacterium Bacillus subtilis MTCC 10403.
Chakraborty K; Thilakan B; Raola VK
Phytochemistry; 2017 Oct; 142():112-125. PubMed ID: 28704687
[TBL] [Abstract][Full Text] [Related]
19. First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species.
Lauritano C; Martínez KA; Battaglia P; Granata A; de la Cruz M; Cautain B; Martín J; Reyes F; Ianora A; Guglielmo L
Sci Rep; 2020 Mar; 10(1):4929. PubMed ID: 32188923
[TBL] [Abstract][Full Text] [Related]
20. Difficidin class of polyketide antibiotics from marine macroalga-associated Bacillus as promising antibacterial agents.
Chakraborty K; Kizhakkekalam VK; Joy M; Dhara S
Appl Microbiol Biotechnol; 2021 Aug; 105(16-17):6395-6408. PubMed ID: 34415389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
